Claims for Patent: 6,355,415

Summary for Patent: 6,355,415

Title:	Compositions and methods for the use of ribozymes to determine gene function
Abstract:	The present invention provides nucleic acid sequences and methods to define gene function. In particular, the present invention relates to reducing the levels of RNA encoded by a DNA sequence of interest using ribozymes. The present invention further relates to ribozyme sequences, recombinant expression vectors encoding ribozymes as well as host cells and transgenic organisms comprising such expression vectors, and the use of these compositions for the determination of gene function.
Inventor(s):	Wagner; Thomas E. (Greenville, SC), Xie; Yuefeng (Gaitersburg, MD)
Assignee:	Ohio University (Athens, OH)
Application Number:	08/939,366
Patent Claims:	1. A method for detecting changes in a zebrafish cell or in tissue obtained from a zebrafish cell, said changes caused by cleaving mRNA encoded by a gene of interest, comprising: a) providing: i) a zebrafish cell comprising a zebrafish genomic sequence having homology to a human genomic sequence, said zebrafish genomic sequence encoding an RNA sequence containing a substrate cleavage sequence; and ii) a ribozyme sequence capable of cleaving said RNA sequence; b) introducing said ribozyme sequence into said zebrafish cell to generate a manipulated cell, wherein said introducing is under conditions such that said RNA sequence is cleaved by said ribozyme sequence; and c) detecting one or more changes selected from morphological changes and behavioral changes in said manipulated cell relative to said zebrafish cell, or in tissue obtained from said manipulated cell relative to tissue obtained from said zebrafish cell, wherein said behavioral chantges are selected from light tropism and chemical tropism. 2. The method of claim 1, wherein said ribozyme is selected from the group consisting of group I intron ribozyme, ribonuclease P ribozyme, hammerhead ribozyme, hairpin ribozyme and hepatitis delta virus ribozyme. 3. The method of claim 1, wherein said ribozyme is a hammerhead ribozyme comprising a first substrate binding region, a second substrate binding region and a catalytic region, and wherein each of said first and second binding regions consists of 8 nucleotides. 4. The method of claim 1, wherein said substrate cleavage sequence is contained in a loop structure in said RNA sequence. 5. The method of claim 4, wherein said loop structure is selected from the group consisting of a 9-nucleotide loop, a 12-nucleotide loop and a 14-nucleotide loop. 6. The method of claim 1, wherein said ribozyme sequence is operably linked to a promoter sequence comprising an adenovirus type 2-associated RNA I gene promoter sequence. 7. The method of claim 6, wherein said promoter sequence further comprises a promoter sequence selected from the group consisting of tRNA, CMV, RSV, SV40, PEPCK, MT, SR.alpha., P450 family, GAL7, T.sub.7, T.sub.3, SP6, K11 and heat shock protein promoter sequences. 8. The method of claim 1, wherein said promoter sequence comprises a CMV promoter sequence, a T.sub.7 promoter sequence, and a vaRNA I promoter sequence. 9. The method of claim 1, wherein said zebrafish cell is an embryonic cell. 10. The method of claim 1, wherein the introduced ribozyme sequence is expressed in said manipulated cell, and wherein said expression is transient. 11. The method of claim 1, wherein the introduced ribozyme sequence is expressed in said manipulated cell, and wherein said expression is stable. 12. A method for detecting changes in a zebrafish oocyte or in tissue obtained from a zebrafish oocyte, said changes caused by cleaving mRNA encoded by a gene of interest, comprising: a) providing: i) a zebrafish oocyte comprising a zebrafish genomic sequence having homology to a human genomic sequence, said zebrafish genomic sequence encoding an RNA sequence; and ii) a ribozyme sequence capable of cleaving said RNA sequence; b) introducing said ribozyme sequence into said zebrafish oocyte to generate a manipulated oocyte, wherein said introducing is under conditions such that said RNA sequence is cleaved by said ribozyme sequence; and c) detecting one or more changes selected from morphological changes and behavioral changes in said manipulated oocyte relative to said zebrafish oocyte, or in tissue obtained from said manipulated oocyte relative to tissue obtained from said zebrafish oocyte, wherein said behavioral chances are selected from light tropism and chemical tropism. 13. The method of claim 12, wherein said ribozyme sequence is operably linked to a promoter sequence comprising an adenovirus type 2-associated RNA I gene promoter sequence. 14. The method of claim 13, wherein said promoter sequence further comprises a promoter sequence selected from the group consisting of tRNA, CMV, RSV, SV40, PEPCK, MT, SR.alpha., P450 family, GAL7, T.sub.7, T.sub.3, SP6, K11 and heat shock protein promoter sequences. 15. The method of claim 12, wherein said promoter sequence comprises a CMV promoter sequence, a T.sub.7 promoter sequence, and a vaRNA I promoter sequence. 16. The method of claim 12, wherein the introduced ribozyme sequence is expressed in said manipulated cell, and wherein said expression is transient. 17. The method of claim 12, further comprising step d) identifying at least one function for said zebrafish genomic sequence. 18. A method for detecting changes in a zebrafish cell or in tissue obtained from a zebrafish cell, said changes caused by cleaving mRNA encoded by a gene of interest, comprising: a) providing: i) a zebrafish cell, said zebrafish cell is transparent and comprises a zebrafish genomic sequence having homology to a human genomic sequence, said zebrafish genomic sequence encoding an RNA sequence; and ii) a ribozyme sequence capable of cleaving said RNA sequence; b) introducing said ribozyme sequence into said zebrafish cell to generate a manipulated cell, wherein said introducing is under conditions such that said RNA sequence is cleaved by said ribozyme sequence; and c) detecting one or more changes selected from morphological changes and behavioral changes in said manipulated cell relative to said zebrafish cell, or in tissue obtained from said manipulated cell relative to tissue obtained from said zebrafish cell, wherein said behavioral changes are selected from light tropism and chemical tropism. 19. The method of claim 18, wherein said ribozyme sequence is operably linked to a promoter sequence comprising an adenovirus type 2-associated RNA I gene promoter sequence. 20. The method of claim 19, wherein said promoter sequence further comprises a promoter sequence selected from the group consisting of tRNA, CMV, RSV, SV40, PEPCK, MT, SR.alpha., P450 family, GAL.sub.7, T.sub.7, T.sub.3, SP6, K11 and heat shock protein promoter sequences. 21. The method of claim 18, wherein said promoter sequence comprises a CMV promoter sequence, a T.sub.7 promoter sequence, and a vaRNA I promoter sequence. 22. The method of claim 18, wherein the introduced ribozyme sequence is expressed in said manipulated cell, and wherein said expression is transient. 23. The method of claim 18, further comprising step d) identifying at least one function for said zebrafish genomic sequence. 24. The method of claim 1, further comprising step d) identifying at least one function for said zebrafish genomic sequence. 25. A method for detecting changes in zebrafish, said changes caused by cleaving mRNA encoded by a gene of interest, comprising: a) providing: i) a fertilized zebrafish oocyte, said fertilized oocyte comprising a zebrafish genomic sequence having homology to a human genomic sequence, said zebrafish genomic sequence encoding an RNA sequence containing a substrate cleavage sequence; and ii) a ribozyme sequence capable of cleaving said RNA sequence; b) introducing said ribozyme sequence into said fertilized oocyte to generate a manipulated fertilized oocyte, wherein said introducing is under conditions such that said RNA sequence is cleaved by said ribozyme sequence; c) permitting said manipulated fertilized oocyte to develop into a manipulated zebrafish offspring; and d) detecting one or more changes selected from morphological changes and behavioral changes in said manipulated zebrafish offspring relative to control zebrafish offspring, wherein said behavioral changes are selected from light tropism and chemical tropism. 26. A method for detecting changes in tissue obtained from a zebrafish cell, said changes caused by cleaving mRNA encoded by a gene of interest, comprising: a) providing: i) a zebrafish cell comprising a zebrafish genomic sequence having homology to a human genomic sequence, said zebrafish genomic sequence encoding an RNA sequence containing a substrate cleavage sequence; and ii) a ribozyme sequence capable of cleaving said RNA sequence; b) introducing said ribozyme sequence into said zebrafish cell to generate a manipulated cell, wherein said introducing is under conditions such that said RNA sequence is cleaved by said ribozyme sequence; and c) detecting one or more morphological changes in tissue obtained from said manipulated cell relative to tissue obtained from said zebrafish cell.

Details for Patent 6,355,415

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26